222 related articles for article (PubMed ID: 18644876)
1. The antifungal vaccine derived from the recombinant N terminus of Als3p protects mice against the bacterium Staphylococcus aureus.
Spellberg B; Ibrahim AS; Yeaman MR; Lin L; Fu Y; Avanesian V; Bayer AS; Filler SG; Lipke P; Otoo H; Edwards JE
Infect Immun; 2008 Oct; 76(10):4574-80. PubMed ID: 18644876
[TBL] [Abstract][Full Text] [Related]
2. Th1-Th17 cells mediate protective adaptive immunity against Staphylococcus aureus and Candida albicans infection in mice.
Lin L; Ibrahim AS; Xu X; Farber JM; Avanesian V; Baquir B; Fu Y; French SW; Edwards JE; Spellberg B
PLoS Pathog; 2009 Dec; 5(12):e1000703. PubMed ID: 20041174
[TBL] [Abstract][Full Text] [Related]
3. Antibody titer threshold predicts anti-candidal vaccine efficacy even though the mechanism of protection is induction of cell-mediated immunity.
Spellberg B; Ibrahim AS; Lin L; Avanesian V; Fu Y; Lipke P; Otoo H; Ho T; Edwards JE
J Infect Dis; 2008 Apr; 197(7):967-71. PubMed ID: 18419471
[TBL] [Abstract][Full Text] [Related]
4. Preclinical Efficacy of Clumping Factor A in Prevention of Staphylococcus aureus Infection.
Li X; Wang X; Thompson CD; Park S; Park WB; Lee JC
mBio; 2016 Feb; 7(1):e02232-15. PubMed ID: 26838725
[TBL] [Abstract][Full Text] [Related]
5. NDV-3, a recombinant alum-adjuvanted vaccine for Candida and Staphylococcus aureus, is safe and immunogenic in healthy adults.
Schmidt CS; White CJ; Ibrahim AS; Filler SG; Fu Y; Yeaman MR; Edwards JE; Hennessey JP
Vaccine; 2012 Dec; 30(52):7594-600. PubMed ID: 23099329
[TBL] [Abstract][Full Text] [Related]
6. Considerable differences in vaccine immunogenicities and efficacies related to the diluent used for aluminum hydroxide adjuvant.
Lin L; Ibrahim AS; Avanesian V; Edwards JE; Fu Y; Baquir B; Taub R; Spellberg B
Clin Vaccine Immunol; 2008 Mar; 15(3):582-4. PubMed ID: 18184821
[TBL] [Abstract][Full Text] [Related]
7. NDV-3 protects mice from vulvovaginal candidiasis through T- and B-cell immune response.
Ibrahim AS; Luo G; Gebremariam T; Lee H; Schmidt CS; Hennessey JP; French SW; Yeaman MR; Filler SG; Edwards JE
Vaccine; 2013 Nov; 31(47):5549-56. PubMed ID: 24063977
[TBL] [Abstract][Full Text] [Related]
8. c-di-GMP as a vaccine adjuvant enhances protection against systemic methicillin-resistant Staphylococcus aureus (MRSA) infection.
Hu DL; Narita K; Hyodo M; Hayakawa Y; Nakane A; Karaolis DK
Vaccine; 2009 Jul; 27(35):4867-73. PubMed ID: 19406185
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of the anti-Candida rAls3p-N or rAls1p-N vaccines against disseminated and mucosal candidiasis.
Spellberg BJ; Ibrahim AS; Avanesian V; Fu Y; Myers C; Phan QT; Filler SG; Yeaman MR; Edwards JE
J Infect Dis; 2006 Jul; 194(2):256-60. PubMed ID: 16779733
[TBL] [Abstract][Full Text] [Related]
10. Protection of mice against Staphylococcus aureus infection by a recombinant protein ClfA-IsdB-Hlg as a vaccine candidate.
Delfani S; Mohabati Mobarez A; Imani Fooladi AA; Amani J; Emaneini M
Med Microbiol Immunol; 2016 Feb; 205(1):47-55. PubMed ID: 26155981
[TBL] [Abstract][Full Text] [Related]
11. Protective efficacy of the chimeric Staphylococcus aureus vaccine candidate IC in sepsis and pneumonia models.
Yang L; Cai C; Feng Q; Shi Y; Zuo Q; Yang H; Jing H; Wei C; Zhuang Y; Zou Q; Zeng H
Sci Rep; 2016 Feb; 6():20929. PubMed ID: 26865417
[TBL] [Abstract][Full Text] [Related]
12. The novel combinations of CTB, CpG, and aluminum hydroxide significantly enhanced the immunogenicity of clumping factor A
Ma J; Wang B; Yu L; Song B; Yu Y; Wu S; Dong Y; Zhu Z; Cui Y
Biosci Biotechnol Biochem; 2020 Sep; 84(9):1846-1855. PubMed ID: 32501144
[TBL] [Abstract][Full Text] [Related]
13. Vaccination with Secreted Aspartyl Proteinase 2 Protein from
Shukla M; Rohatgi S
Infect Immun; 2020 Sep; 88(10):. PubMed ID: 32661125
[TBL] [Abstract][Full Text] [Related]
14. Protective efficacy of a novel alpha hemolysin subunit vaccine (AT62) against Staphylococcus aureus skin and soft tissue infections.
Adhikari RP; Thompson CD; Aman MJ; Lee JC
Vaccine; 2016 Dec; 34(50):6402-6407. PubMed ID: 27847174
[TBL] [Abstract][Full Text] [Related]
15. A cell wall protein-based vaccine candidate induce protective immune response against Sporothrix schenckii infection.
Portuondo DL; Batista-Duharte A; Ferreira LS; MartÃnez DT; Polesi MC; Duarte RA; de Paula E Silva AC; Marcos CM; Almeida AM; Carlos IZ
Immunobiology; 2016 Feb; 221(2):300-9. PubMed ID: 26547105
[TBL] [Abstract][Full Text] [Related]
16. Recombinant Staphylococcal Antigen-F (r-ScaF), a novel vaccine candidate against methicillin resistant Staphylococcus aureus infection: Potency and efficacy studies.
Majelan PA; Mahdavi M; Yazdi MH; Salimi E; Pourmand MR
Microb Pathog; 2019 Feb; 127():159-165. PubMed ID: 30521844
[TBL] [Abstract][Full Text] [Related]
17. Hybrid phage displaying SLAQVKYTSASSI induces protection against Candida albicans challenge in BALB/c mice.
Wang Y; Su Q; Dong S; Shi H; Gao X; Wang L
Hum Vaccin Immunother; 2014; 10(4):1057-63. PubMed ID: 24448202
[TBL] [Abstract][Full Text] [Related]
18. Targeting the R domain of coagulase by active vaccination protects mice against lethal Staphylococcus aureus infection.
Qian M; Zhao T; Li R; Yang Q; Yu R; Yin Y; Zai X; Li Y; Zhang J; Xu J; Chen W
Microbes Infect; 2019; 21(3-4):163-169. PubMed ID: 30447395
[TBL] [Abstract][Full Text] [Related]
19. Recombinant ESAT-6-like proteins provoke protective immune responses against invasive Staphylococcus aureus disease in a murine model.
Zhang BZ; Hua YH; Yu B; Lau CC; Cai JP; Zheng SY; Yam WC; Kao RY; Sze KH; Zheng BJ; Yuen KY; Huang JD
Infect Immun; 2015 Jan; 83(1):339-45. PubMed ID: 25368117
[TBL] [Abstract][Full Text] [Related]
20. The NDV-3A vaccine protects mice from multidrug resistant Candida auris infection.
Singh S; Uppuluri P; Mamouei Z; Alqarihi A; Elhassan H; French S; Lockhart SR; Chiller T; Edwards JE; Ibrahim AS
PLoS Pathog; 2019 Aug; 15(8):e1007460. PubMed ID: 31381597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
